Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SPNE

SeaSpine (SPNE) Stock Price, News & Analysis

SeaSpine logo

About SeaSpine Stock (NASDAQ:SPNE)

Key Stats

Today's Range
$8.43
$9.67
50-Day Range
$7.03
$9.54
52-Week Range
$5.48
$14.23
Volume
1.16 million shs
Average Volume
822,700 shs
Market Capitalization
$354.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SPNE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaSpine and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SPNE Stock News Headlines

AI's Next Magnificent Seven
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel
Spine Biologics Market Size to Achieve USD 6.95 Bn by 2033
See More Headlines

SPNE Stock Analysis - Frequently Asked Questions

SeaSpine Holdings Co. (NASDAQ:SPNE) announced its quarterly earnings results on Thursday, October, 28th. The medical equipment provider reported ($0.48) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by $0.17. The company's quarterly revenue was up 7.5% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that SeaSpine investors own include AbbVie (ABBV), Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Amarin (AMRN), Alphatec (ATEC), Meta Platforms (META) and uniQure (QURE).

Company Calendar

Last Earnings
10/28/2021
Today
10/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SPNE
CIK
1637761
Fax
N/A
Employees
523
Year Founded
2015

Profitability

EPS (Trailing Twelve Months)
($1.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.35 million
Net Margins
-28.22%
Pretax Margin
-28.83%
Return on Equity
-22.16%
Return on Assets
-17.09%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
3.18
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$191.45 million
Price / Sales
1.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.57 per share
Price / Book
1.11

Miscellaneous

Outstanding Shares
37,203,000
Free Float
33,736,000
Market Cap
$354.92 million
Optionable
Optionable
Beta
1.31

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:SPNE) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners